Genentech Oncology
Our initiatives are based on a simple premise: that an improved journey for people with cancer is both necessary and achievable. With patient needs at the forefront, our patient experience efforts are spread across five areas:
to cancer treatments, screening awareness programs, and diagnostic tests for all patients
to reach patients where they are
that truly meet patient needs
with the potential for greater convenience, lower costs, improved patient experience, and availability across sites of care
that improves patient access to quality care
4R is a care sequence tool that puts people with cancer in the driver’s seat, empowering them to help plan and manage their care.
View the full case study to learn more about the 4R tool and how it has been shown to help advance patient care.
Genentech is working with the American Cancer Society to provide equitable access to care for every person with cancer and their family, with a focus on underserved populations. Goals include expanding the programmatic reach of patient navigation programs, psychosocial care for patients and their families, increased access to biomarker testing and emerging therapies, and increased representation in clinical trials.
View the full case study to learn more about how we’re working together and find resources from the American Cancer Society and Genentech for use as needed by your organization here.
Innovation in drug formulations, including co-formulations, subcutaneous regimens, and fixed-duration regimens enables us to provide a greater number of options at lower cost to patients and society, available across sites of care, without sacrificing effectiveness. Genentech is committed to innovating in dosing and delivery options to provide customers greater choice and flexibility in serving patients.
Learn more about the impact of drug delivery on patient experience.
We are a founding sponsor of the American Cancer Society’s (ACS) Get Screened initiative, which is intended to rapidly restore and improve screening rates in communities that have faced historical inequities and have been most strongly impacted by the pandemic. Since the launch of this initiative in 2020, we have seen approximately 1.2M new screenings conducted and approximately 16,000 cancers diagnosed that may not have otherwise been found.
Learn more about how this cancer screening awareness program can help patients within your community.
Genentech is committed to improving the accessibility of our medicines and making the process more streamlined and patient-friendly. Our Patient Support Services help people understand their health insurance coverage and costs related to Genentech medicines, support people who do not have health insurance and meet eligibility criteria, provide co-pay assistance or starter programs, and connect patients with organizations that can help them afford their treatment. We remain committed to helping patients access our medicines, regardless of the ability to pay, and will continue to advance our programs to ensure they benefit the patients who truly need them.
Explore to better understand how our patient support services might help your patients.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.